ÂÜÀòÂÒÂ×

Anne-Marie McNicol is currently the Senior Director of Global Regulatory Affairs at Adaptimmune. Anne-Marie has held various regulatory roles in top companies such as FreeLine, GSK, Novella Clinical, and Great Ormond Street Hospital & University College London. Anne-Marie has a strong background in gene therapy and oncology regulatory affairs, with a focus on developing appropriate regulatory strategies for T-cell receptor gene therapy oncology programs. Anne-Marie has a solid educational background with a PhD in Development of T-cell receptor gene therapy strategies for tumour immunotherapy from Imperial College London.